Fracture protection in osteoporosis with risedronate.
Boonen
Steven
S
Leuven University Center for Metabolic Bone Diseases, Katholieke Universiteit Leuven, Leuven, Belgium.
Vanderschueren
Dirk
D
D000368:Aged; D015519:Bone Density; D004164:Diphosphonates / Q000627:therapeutic use*; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology; D010349:Patient Compliance; D000068296:Risedronic Acid; D012307:Risk Factors
D004164:Diphosphonates; D000068296:Risedronic Acid; D012968:Etidronic Acid